Morphic Announces Participation in 2022 RBC Capital Markets Global Healthcare Conference
Morphic Therapeutic (MORF), a biopharmaceutical company focused on oral integrin therapies, announced that its management team will participate in a fireside chat at RBC Capital Markets on May 18 at 8:00 AM ET. A live webcast will be accessible on the Investor section of Morphic’s website, with an archived replay available post-conference. Morphic is advancing its pipeline through collaborations with AbbVie, Janssen, and Schrödinger, utilizing its proprietary MInT technology platform to target serious chronic diseases, including autoimmune and metabolic conditions.
- None.
- None.
WALTHAM, Mass., May 17, 2022 (GLOBE NEWSWIRE) -- Morphic Therapeutic (Nasdaq: MORF), a biopharmaceutical company developing a new generation of oral integrin therapies for the treatment of serious chronic diseases, today announced that members of its management team will participate in a fireside chat at the RBC Capital Markets on Wednesday, May 18that 8:00 AM ET.
A live webcast of the event will be available on the Investor section of Morphic’s website at www.morphictx.com. An archived replay will be available on the company’s website following the conference.
About Morphic Therapeutic
Morphic Therapeutic is a biopharmaceutical company developing a new generation of oral integrin therapies for the treatment of serious chronic diseases, including autoimmune, cardiovascular, and metabolic diseases, fibrosis, and cancer. In collaboration with AbbVie, Janssen, and Schrödinger, Morphic is advancing its pipeline and discovery activities using its proprietary MInT technology platform which leverages the Company’s unique understanding of integrin structure and biology. For more information, visit www.morphictx.com.
Contacts
Morphic Therapeutic
Chris Erdman
chris.erdman@morphictx.com
617.686.1718
FAQ
What event is Morphic Therapeutic participating in on May 18, 2022?
Where can I watch the webcast of Morphic Therapeutic's event?
What type of therapies is Morphic Therapeutic developing?
Who are Morphic Therapeutic's collaborators in developing its therapies?
